GlassScriptPhysician profile
James J Taylor
NPI 1225087380
$10,797.18
in general payments reported to CMS, 2019-2025
24 companies · $352 in 2025
The $352 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $163 · 2020: $636 · 2021: $369 · 2022: $8,173 · 2023: $383 · 2024: $722 · 2025: $352.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,456.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,456.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Octapharma USA, INC. | $8,102.61 | 2022 | |
| Medtronic Vascular, INC. | $610.70 | 2019-2020 | |
| Silk Road Medical, INC. | $388.53 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Ethicon US, LLC | $247.11 | 2021-2025 | Echelon Endopath, Echelon; Endopath |
| Intuitive Surgical, INC. | $219.20 | 2021 | |
| Atricure, INC. | $215.99 | 2023-2025 | Atriclip Laa Exclusion System, Synergy Ablation System, Epi-Sense Guided Coagulation System With Visitrax |
| Davol INC. | $163.61 | 2023 | Progel Applicator Spray Tips |
| Medtronic, INC. | $150.00 | 2024 | Endurant Iis |
| Edwards Lifesciences Corporation | $139.81 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Covidien LP | $128.48 | 2020 | |
| Abiomed | $78.04 | 2025 | |
| Tactile Systems Technology INC | $56.18 | 2022 | |
| Abbott Laboratories | $45.26 | 2019-2021 | |
| Boston Scientific Corporation | $41.09 | 2019 | |
| Amgen INC. | $34.95 | 2024 | Repatha |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lifenet Health | $28.00 | 2025 | Theragenesis Wound Matrix |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.51 | 2025 | Lifevest |
| Kiniksa Pharmaceuticals International, Plc | $20.57 | 2024 | Arcalyst |
| Astrazeneca Pharmaceuticals LP | $19.53 | 2025 | Wainua |
| Novartis Pharmaceuticals Corporation | $17.84 | 2024 | |
| Merck Sharp & Dohme LLC | $17.61 | 2025 | Verquvo |
| Angiodynamics, INC. | $17.27 | 2024 | Angiovac |
| Lexicon Pharmaceuticals, INC. | $15.84 | 2024 | |
| Zimmer Biomet Holdings, INC. | $14.45 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Taylor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.